People who suffered life-threatening episodes of Xarelto internal bleeding may not live to tell the tale, as this injury is often difficult to reverse, and has resulted in death for an alleged many. While internal bleeding from a blood thinner is not uncommon, this side effect in Xarelto users is especially harmful. Bleeding effects from warfarin, a decades-old blood thinner, may be reversed with Vitamin K.
Despite this serious risk, Xarelto continues to be prescribed throughout the U.S. to patients with atrial fibrillation as well as those who may be at risk for blood clots after hip replacement surgery, and in the treatment of deep vein thrombosis and pulmonary embolism, among other uses. The attorneys at Bernstein Liebhard LLP are eager to speak with individuals who suffered Xarelto bleeding and may be eligible to compensation for damages incurred by their injuries. Call to speak with the Firm directly at 212-779-1414.
Court records indicate that Xarelto bleeding reports have already been filed by individuals who claim to have suffered the following side effects:
People who claim to have been injured by Xarelto have also come forward to file lawsuits against Bayer Healthcare and Janssen Pharmaceuticals, who jointly market the medication. As of September 2014, many of these cases were pending in the Philadelphia Court of Common Pleas, after being filed by plaintiffs who accuse the companies of failing to adequately warn users of the blood thinner that there was no reversal agent to stop life-threatening episodes of internal bleeding. Xarelto is also improperly marketed as an improvement over warfarin, which can be reversed via Vitamin K, lawsuits allege.
In the first quarter of 2013, an analysis from the Institute of Safe Medicine Practices found that 680 complaints involving Xarelto had been filed in the U.S. Food and Drug Administration (FDA)’s adverse event report database. Complications associated with this blood thinner surpassed the number associated with Pradaxa, a similar medication, for the first time, the ISMP reported.
Xarelto was first cleared by the FDA in 2011, and was marketed as a convenient alternative to warfarin, which is sold as Coumadin. Xarelto does not require that patients undergo frequent blood tests or restrict their diet, unlike warfarin. Just a year later, the ISMP found that the new-generation blood thinner had been included in 2,000 adverse event reports, many of which noting life-threatening episodes of internal bleeding. 151 fatal incidents were also recorded in 2012.
The ISMP report also found a 7.2 percent risk of death in Xarelto bleeding victims, compared to the 6.5 percent of patients who were likely to die after use of warfarin.
If you take this medication and are experiencing the following symptoms, it is urgent that you seek medical attention right away. These may be signs of Xarelto internal bleeding:
Call the attorneys at Bernstein Liebhard LLP for a free and confidential evaluation of your Xarelto Lawsuit today. Contact the Firm right away by calling: 212-779-1414.